India’s Drug controller general of India(DCGI) gives permission to Bharat Biotech for Phase -3 clinical trials after completion of Phase -1 and Phase 2 trials of COVAXIN. The phase-3 clinical trials will be done in 25 centre in 26,000 participants across India.
Fruit juices have long been hailed as a healthy, refreshing way to hydrate and get…
A recent isolated case of Japanese Encephalitis (JE) in Delhi has raised questions about the…
Expert Shares Key Tips and Tricks to Help You Identify Fake Saffron Saffron, known as…
Growing Concern of Sciatica Among Indians: Insights on Prevention and Treatment Sciatica, a condition characterized…
The Indian Council of Medical Research (ICMR) plays a pivotal role in promoting health and…
The 19 Foods You CAN Eat Past Their Expiry Date: A Comprehensive Guide When it…